Use of NSAIDs in triathletes: Prevalence, level of awareness and reasons for use

British Journal of Sports Medicine

Volumn 45, Issue 2, 2011, Pages 85-90

  Gorski, T ^a   Lusa Cadore, E ^a   Santana Pinto, S ^a   Marczwski Da Silva, E ^a   Silva Correa, C ^a   Gabe Beltrami, F ^b   Martins Kruel, L F ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; ATHLETE; ATTITUDE TO HEALTH; BICYCLE; BRAZIL; FEMALE; HUMAN; MALE; PAIN; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RUNNING; SPORT INJURY; STATISTICS; SWIMMING;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATHLETES; ATHLETIC INJURIES; BICYCLING; BRAZIL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PAIN; QUESTIONNAIRES; RUNNING; SWIMMING;

EID: 79551490768     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsm.2009.062166     Document Type: Article

References (28)

1. Lieberman M, Marks A, Smith CM, et al. Metabolism of the eicosanoids. Mark's basic medical biochemistry: a clinical approach. 3rd edn. Philadelphia (PA): Lippincott Williams & Wilkins, 2005:671-84.
2. Wannmacher L, Bredemeier M. Antiinflamatórios não- esteróides: uso indiscriminado de inibidores seletivos de cicloxigenase-2. ISSN 1810-0791. 2004;1(2):1-6.
3. Nelson DL, Cox MM. Lipid biosynthesis. In: Nelson DL, Cox MM, eds. Lehninger principles of biochemistry. 4th edn. New York (NY): W. H. Freeman and Company, 2005:787-832.
4. Catella-Lawson F, Reilly M P, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001;345:1809-17.
5. Armstrong PC, Truss NJ, Ali FY, et al. Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2. J Thromb Haemost 2008;6:1933-43.
6. Graff J, Skarke C, Klinkhardt U, et al. Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers. J Thromb Haemost 2007;5:2376-85.
7. Warner DC, Schnepf G, Barrett MS, et al. Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes. J Adolesc Health 2002;30:150-3.
8. Corrigan B, Kazlauskas R. Medication use in athletes selected for doping control at the Sydney Olympics (2000). Clin J Sport Med 2003;13:33-40.
9. Reid SA, Speedy DB, Thompson JM, et al. Study of hematological and biochemical parameters in runners completing a standard marathon. Clin J Sport Med 2004;14:344-53.
10. Nieman DC, Dumke CL, Henson DA, et al. Muscle damage is linked to cytokine changes following a 160-km race. Brain Behav Immun 2005;19:398-403.
11. Huang SH, Johnson K, Pipe AL. The use of dietary supplements and medications by Canadian athletes at the Atlanta and Sydney Olympic Games. Clin J Sport Med 2006;16:27-33.
12. Wharam PC, Speedy DB, Noakes TD, et al. NSAID use increases the risk of developing hyponatremia during an Ironman triathlon. Med Sci Sports Exerc 2006;38:618-22.
13. De Rose EH, Feder MG, Pedroso PR et al. Referred use of medication and dietary supplements in athletes selected for doping control in the South-American Games. Rev Bras Med Esporte 2006;12:215e-17e.
14. Alaranta A, Alaranta H, Heliövaara M, et al. Ample use of physician-prescribed medication in Finnish elite athletes. Int J Sports Med 2006;27:919-25.
15. Page AJ, Reid SA, Speedy DB, et al. Exercise-associated hyponatremia, renal function, and nonsteroidal antiinflamatory drug use in an ultraendurance mountain run. Clin J Sport Med 2007;17:43-8.
16. Taioli E. Use of permitted drugs in Italian professional soccer players. Br J Sports Med 2007;41:439-41.
17. Tscholl P, Junge A, Dvorak J. The use of medication and nutritional supplements during FIFA World Cups 2002 and 2006. Br J Sports Med 2008;42:725-30.
18. Thuyne WV, Delbeke FT. Declared use of medication in sports. Clin J Sport Med 2008;18:143-7.
19. Tscholl P, Feddermann N, Junge A, et al. The use and abuse of painkillers in international soccer: data from 6 FIFA tournaments for female and youth players. Am J Sports Med 2009;37:260-5.
20. Ciocca M. Medication and supplement use by athletes. Clin Sports Med 2005;24:719-38.
21. Hertel J. The role of nonsteroidal anti-inflammatory drugs in the treatment of acute soft tissue injuries. J Athl Train 1997;32:350-8.
22. Martin DE, Coe PN. Better training for distance runners. 2nd edn. Champaign (IL): Human Kinetics, 1997.
23. Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol 2005;32:2218-24.
24. Desbrow B, Leveritt M. Well-trained endurance athletes' knowledge, insight, and experience of caffeine use. Int J Sport Nutr Exerc Metab 2007;17:328-39.
25. Baker J, Cotter JD, Gerrard DF, et al. Effects of indomethacin and celecoxib on renal function in athletes. Med Sci Sports Exerc 2005;37:712-17.
26. Walker RJ, Fawcett J P, Flannery EM, et al. Indomethacin potentiates exerciseinduced reduction in renal hemodynamics in athletes. Med Sci Sports Exerc 1994;26:1302-6.
27. Davis DP, Videen JS, Marino A, et al. Exercise-associated hyponatremia in marathon runners: a two-year experience. J Emerg Med 2001;21:47-57.
28. Shoor S. Athletes, nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Curr Sports Med Rep 2002;1:107-15.